A Novel Method to Determine the Maximum Output of Individual Patients for an Active Transcutaneous Bone Conduction Implant Using Clinical Routine Data.

The study did not use masked direct bone conduction thresholds, which are the gold standard for determining which ear perceives the sound. Researchers had to infer the side of perception based on unmasked thresholds and transcranial attenuation estimates, introducing potential error. The transcranial attenuation values used for grouping were median values from previous literature (Stenfelt 2012), not individual measurements from these patients, which may not accurately reflect the specific implant sites used in this study. The method predicts the theoretically possible maximum output, not the actual output achieved in a clinical fitting, which is limited by feedback and gain settings. This is a retrospective analysis of existing data, not a prospective trial testing patient outcomes or speech recognition performance with the new method.

The work was funded by the German Research Foundation (DFG). Three authors (M. G., S. B., and H. M.) received travel support to conferences from MED-EL, the manufacturer of the Bonebridge device. The authors declare no other conflicts of interest.

Do not assume this method changes clinical practice immediately. It calculates a theoretical maximum output based on device specifications and thresholds, not the actual audible output a patient experiences in a real-world fitting. Furthermore, the study suggests current indication limits might be too conservative, but it did not test whether expanding these limits actually improves patient outcomes.